5 Key Takeaways

• 1

  A new stem cell treatment has improved vision in patients with aniridia-related keratopathy (ARK), a previously untreatable genetic eye condition.

• 2

  The treatment was developed by researchers at Moorfields Eye Hospital and the UCL Institute of Ophthalmology and tested in nine patients.

• 3

  Patients showed substantial improvements in ocular surface scores, decreasing from an average of 9.4 to 5.9 after three months.

• 4

  Vision improved by an average of 24 letters on the ETDRS eye test, equivalent to almost five lines on a standard vision chart.

• 5

  Researchers plan to advance this treatment to a larger clinical trial with the goal of NHS acceptance.